Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer AG
Original Assignee
Bayer AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer AGfiledCriticalBayer AG
Publication of ES309588A1publicationCriticalpatent/ES309588A1/en
Pharmaceuticals Containing Other Organic And Inorganic Compounds
(AREA)
Abstract
Process for the preparation of substituted imidazolidines of the formula ** (See formula) ** characterized in that the urea derivatives of the formula ** (See formula) ** where Y and Z signify oxygen or sulfur, X hydrogen, alkyl with 1-2 carbon atoms and/or halogen and R hydrogen, an aliphatic radical with 1-5 carbon atoms, if substituted by halogen, are reacted with chloride oxalyl or other derivative of oxalic acid capable of reaction. (Machine-translation by Google Translate, not legally binding)
ES0309588A1964-02-211965-02-20Procedure for obtaining substitute imidazolidines. (Machine-translation by Google Translate, not legally binding)
ExpiredES309588A1
(en)
Procedure for the preparation of new oxazolinic and tiazolinic derivatives with nematocide action (Machine-translation by Google Translate, not legally binding)
Procedure for the monohydration of the equimolecular complex formed by ascorbic acid and pyridoxine. (Machine-translation by Google Translate, not legally binding)
A procedure for the polycondensation of acid amidas rent, alquiliden, and aralquiliden-bis-halºgenocarboxºlico (Machine-translation by Google Translate, not legally binding)